{"organizations": [], "uuid": "613eba35a9dff6f45ca6a67d08442a3512e930cf", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-intercept-pharmaceuticals-ceo-mark/brief-intercept-pharmaceuticals-ceo-mark-pruzanskis-fy-2017-total-compensation-was-6-2-million-idUSFWN1S41RU", "country": "US", "domain_rank": 408, "title": "BRIEF-Intercept Pharmaceuticals CEO Mark Pruzanski's FY 2017 Total Compensation Was $6.2 Million", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-28T00:28:00.000+03:00", "replies_count": 0, "uuid": "613eba35a9dff6f45ca6a67d08442a3512e930cf"}, "author": "", "url": "https://www.reuters.com/article/brief-intercept-pharmaceuticals-ceo-mark/brief-intercept-pharmaceuticals-ceo-mark-pruzanskis-fy-2017-total-compensation-was-6-2-million-idUSFWN1S41RU", "ord_in_thread": 0, "title": "BRIEF-Intercept Pharmaceuticals CEO Mark Pruzanski's FY 2017 Total Compensation Was $6.2 Million", "locations": [], "entities": {"persons": [{"name": "mark pruzanski", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "sec", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "million reuters staff", "sentiment": "none"}, {"name": "min read  intercept pharmaceuticals inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 27 (Reuters) - Intercept Pharmaceuticals Inc:\n* INTERCEPT PHARMACEUTICALS SAYS CEO MARK PRUZANSKI'S FY 2017 TOTAL COMPENSATION WAS $6.2 MILLION VERSUS $4.8 MILLION IN 2016 - SEC FILING Source text for Eikon: ( bit.ly/2KlDqOX ) Further company coverage:\n ", "external_links": ["http://bit.ly/2KlDqOX"], "published": "2018-04-28T00:28:00.000+03:00", "crawled": "2018-04-28T00:46:13.006+03:00", "highlightTitle": ""}